Inspire Medical Systems, Inc. INSP
Set alert
67.25 USD -0.85 -1.25%
As of Nov 2, 3:47 PM ET
65.80 Day range 69.29
38.91 52-week range 147.03
- YTD
- -27.08%
- 1 year
- -6.70%
- Open
- 68.71
- Prev close
- 68.10
- Mkt cap
- 1.95B
- Vol
- 631.41K
- Avg vol
- 774.85K
- EPS
- 4.54
- P/E
- 14.84
- Div yield
- 0.00%
More statistics
- Low
- 65.80
- High
- 69.29
- Forward P/E
- 44.32
- Beta
- 0.73
- Short ratio
- 4.74
- Inst. own
- 129.28%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 2, 2026
- 50-d avg
- 68.45
- 200-d avg
- 58.70
- 1y target
- 68.00
6M chart
Events in this range
- May 4, 2026Earnings: 0.1; estimate -0.27533; surprise 136.32%
- Aug 3, 2026Earnings: 0.14; estimate -0.23592; surprise 159.34%
- Sep 11, 2026Rating: Stifel · Buy → Buy
- Sep 21, 2026Rating: Freedom Capital Markets · Buy → Buy
- Oct 1, 2026Rating: RBC Capital · Sector Perform → Sector Perform
- Oct 2, 2026Rating: Freedom Capital Markets · Buy → Buy
- Oct 7, 2026Rating: Barclays · — → Underweight
- Oct 14, 2026Rating: Truist Securities · Hold → Hold
- Nov 2, 2026Earnings: —; estimate 0.08701; surprise —%
Signals (24)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 30, 2026 | 3 days ago |
| MACD: Sell Signal | Oct 26, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 22, 2026 | 1 week ago |
| MACD: Sell Signal | Sep 23, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 10, 2026 | 1 month ago |
| RSI: Overbought | Sep 10, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 26, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 14, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 4, 2026 | 3 months ago |
| RSI: Overbought | Aug 4, 2026 | 3 months ago |
| SMA: Bullish | Jul 27, 2026 | 3 months ago |
| SMA: Bearish | Jul 24, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 24, 2026 | 3 months ago |
| SMA: Bullish | Jul 16, 2026 | 3 months ago |
| SMA: Bearish | Jul 14, 2026 | 3 months ago |
| SMA: Bullish | Jul 9, 2026 | 3 months ago |
| RSI: Overbought | Jul 9, 2026 | 3 months ago |
| SMA: Bullish | Jul 1, 2026 | 4 months ago |
| MACD: Buy Signal | May 22, 2026 | 5 months ago |
| RSI: Oversold | May 15, 2026 | 5 months ago |
| RSI: Oversold | May 13, 2026 | 5 months ago |
| RSI: Oversold | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | May 5, 2026 | 6 months ago |
Key statistics
- Market cap
- 1.97B
- Enterprise value
- 1.77B
- Trailing P/E
- 15.00
- Forward P/E
- 44.32
- PEG ratio
- 0.00
- Price / sales
- 2.19
- Price / book
- 2.38
- EPS (TTM)
- 4.54
- Beta
- 0.73
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 15.03%
- Revenue (TTM)
- 898.74M
- Revenue growth
- -7.60%
- Free cash flow
- 94.64M
- Total cash
- 320.68M
- Total debt
- 29.09M
- Return on equity
- 17.97%
- Shares outstanding
- 28.91M
- Short % of float
- 20.34%
- 50-day average
- 68.45
- 200-day average
- 58.70
Analyst view
Consensus: hold
Hold
Price target (mean) 68.00 +1.1% upside
Now 67.25
- Target (low)
- 40.00
- Target (mean)
- 68.00
- Target (high)
- 97.00
Ratings (0m) 18 4 buy · 11 hold · 3 sell
- Strong buy0
- Buy4
- Hold11
- Sell1
- Strong sell2
Next earnings
Nov 2, 2026
Expected Nov 2, 2026. Consensus EPS estimate 0.09087.
Financials — quick view
INSP Revenue — quarterly 200.58M
INSP Net income — quarterly 314.00K
INSP EPS — quarterly 0.01
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 2, 2026 | Sep 30, 2026 | 0.08701 | — | — | — |
| Aug 3, 2026 | Jun 30, 2026 | -0.23592 | 0.14 | +0.38 | +159.34% |
| May 4, 2026 | Mar 31, 2026 | -0.27533 | 0.10 | +0.38 | +136.32% |
| Feb 11, 2026 | Dec 31, 2025 | 0.69 | 1.65 | +0.96 | +139.13% |
| Nov 3, 2025 | Sep 30, 2025 | -0.15 | 0.38 | +0.53 | +353.33% |
| Aug 4, 2025 | Jun 30, 2025 | 0.22 | 0.45 | +0.23 | +104.55% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 14, 2026 | Truist Securities | main | Hold | Hold |
| Oct 7, 2026 | Barclays | init | — | Underweight |
| Oct 2, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Oct 1, 2026 | RBC Capital | main | Sector Perform | Sector Perform |
| Sep 21, 2026 | Freedom Capital Markets | main | Buy | Buy |
| Sep 11, 2026 | Stifel | main | Buy | Buy |
About Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- inspiresleep.com
News
- INSP Stock Gains 47.8% in Three Months: What's Driving the Rally?
- Truist Securities Maintains Hold on Inspire Medical Systems, Raises Price Target to $78
- Inspire Medical Systems Inc (INSP) Stock Up 3.3% and Still Undervalued -- GF Score: 64/100
- Barclays Initiates Coverage On Inspire Medical Systems with Underweight Rating, Announces Price Target of $65
- Roche Diagnostics delivers laboratory equipment to support Ebola testing in DRC
- Inspire Medical Systems, Inc. to Report Third Quarter 2026 Financial Results on November 2, 2026
- Inspire Medical Gains New CPT Codes for Hypoglossal Nerve Stimulation
- Inspire Medical Systems Receives American Medical Association CPT Editorial Panel Approval To Establish New Set Of Current Procedural Terminology Codes
- Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel
- RBC Capital Maintains Sector Perform on Inspire Medical Systems, Raises Price Target to $75
Your note
Sign in to keep a note on INSP — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BUCHHOLZ RICHARD | Chief Financial Officer | Sale | Aug 28, 2025 | 50,767 |
| HERBERT TIMOTHY P | Chief Executive Officer | Stock Award(Grant) | Feb 19, 2026 | 163,492 |
| KELLY JASON P | Officer | Sale | Aug 6, 2026 | 18,985 |
| MANN MELISSA | Officer | Stock Award(Grant) | Feb 19, 2026 | 23,609 |
| MCCORMICK SHAWN T | Director | Sale | May 7, 2026 | 30,712 |
| MEAD DANA G JR | Director | Stock Award(Grant) | Apr 29, 2026 | 26,213 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 16.39% | 4,737,519 | 322.61M | Jun 29, 2026 |
| Wellington Management Group, LLP | 8.24% | 2,382,660 | 162.25M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 7.23% | 2,088,961 | 142.25M | Jun 29, 2026 |
| Soleus Capital Management, L.P. | 6.68% | 1,931,436 | 131.53M | Jun 29, 2026 |
| AQR Capital Management, LLC | 6.42% | 1,856,800 | 126.44M | Jun 29, 2026 |
| UBS Group AG | 5.69% | 1,645,511 | 112.06M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 7.24% | 2,093,826 | 142.58M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.95% | 1,720,772 | 117.18M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.16% | 914,149 | 62.25M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.59% | 750,208 | 51.09M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.28% | 660,263 | 44.96M | Jun 29, 2026 |
| Artisan Partners Funds Inc.-Artisan International Small-Mid Fund | 1.58% | 456,014 | 31.05M | Jun 29, 2026 |